Ainos

San Diego, United States Founded: 1986 • Age: 40 yrs
Novel point-of-care testing and low-dose interferon therapeutics are developed.
Annual revenue $20,730 Latest available
Total funding - 12 rounds
Employees 44 Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Ainos

Ainos is a company based in San Diego (United States) founded in 1986. The company has 44 employees as of December 31, 2024. Ainos operates in a competitive market with competitors including Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others.

  • Headquarter San Diego, United States
  • Employees 44 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Ainos, Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $20.73 K (USD)
    -83.02
    as on Dec 31, 2024
  • Net Profit
    -$14.86 M (USD)
    -7.93
    as on Dec 31, 2024
  • EBITDA
    -$9.04 M (USD)
    -12.05
    as on Dec 31, 2024
  • Latest Funding Round
    $9 M (USD), Post-IPO

    May 07, 2024

  • Investors
  • Employee Count
    44

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Ainos

Ainos is a publicly listed company on the NASDAQ with ticker symbol AIMD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: AIMD · Sector: Health technology · USA

Funding Insights of Ainos

Investors in Ainos

Ainos has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include The Lind Partners and Firebird Management.

All
Venture Fund
Investor Description Founded Year Domain Location
The Lind Partners is based in New York, USA.
Locked Locked Locked
Firebird Management LLC is engaged in managing investment funds.
Locked Locked Locked
Premium access

Investor details for Ainos

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Ainos

Investments
Premium access

Investment portfolio details for Ainos

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Ainos

Premium access

Detailed financials for Ainos

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ainos Comparisons

Ainos Primary company
Description
Novel point-of-care testing and low-dose interferon therapeu...
Location
San Diego, United States
Founded Year
1986
Annual Revenue
$20.73 K (USD)
Net Profit
-$14.86 M (USD)
EBITDA
-$9.04 M (USD)
Employees
44
As of 2024
Premium access

Peer comparison for Ainos

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Ainos

Ainos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmaron, Pfizer, Boehringer Ingelheim, Lonza and Dotmatics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Drug discovery and development services for small molecules are provided.
Locked Locked Locked
Pharmaceutical products for treating multiple diseases are provided.
Locked Locked Locked
Generic drugs and clinical research services are provided globally.
Locked Locked Locked
CDMO services for pharma, biotech, and specialty ingredients are provided.
Locked Locked Locked
AI powered scientific data management and workflow automation solutions
Locked Locked Locked
Laboratory testing, clinical trial research, and biopharma services are provided.
Premium access

Detailed competitors of Ainos

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ainos

Premium access

Complete news archive for Ainos

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ainos

Ainos was founded in 1986 and raised its 1st funding round 16 years after it was founded.

Ainos is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Chun Hsien Tsai is the current CEO of Ainos.

As of Dec 31, 2024, the latest employee count at Ainos is 44.

Annual revenue of Ainos is $20.73K as on Dec 31, 2024.

Ainos was founded in 1986 and is headquartered in San Diego, United States. Operations are centered in the medtech sector, with focus placed on pharmaceuticals, point-of-care testing, and low-dose interferon therapeutics. Innovative business arms are being developed, alongside new drug candidates and health supplements. Diversification efforts aim to establish leadership in these areas through ongoing research and product advancement.

Ainos's top competitors include Pharmaron, Pfizer and Lonza.

Yes, Ainos is publicly traded on NASDAQ under the ticker symbol AIMD.

Ainos has 2 investors. Key investors include The Lind Partners, and Firebird Management.

The ticker symbol of Ainos is AIMD on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available